Protagonist Therapeutics Inc (PTGX)

Quick ratio

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Cash US$ in thousands 172,568 186,727 230,527 235,382 127,686 125,744 152,816 120,237 98,477 123,665 120,542 192,412 83,000 117,358 83,625 146,242 60,215 33,006 50,195 71,143
Short-term investments US$ in thousands 150,067 154,890 90,224 78,019 103,073 111,611 114,621 171,653 206,800 203,235 193,759 161,868 190,500 188,500 110,349 62,423 57,298 100,011 87,497 54,958
Receivables US$ in thousands 50 51 3,852 620 3,363 28,504 5,333 4,509 9,855 5,819 3,821 3,324 3,273 3,747 7,499 2,118 6,310
Total current liabilities US$ in thousands 39,910 21,274 27,867 26,398 23,229 31,179 36,754 40,088 43,456 44,016 39,156 42,973 34,515 40,241 38,563 35,360 36,372 35,406 30,776 33,323
Quick ratio 8.08 16.06 11.51 11.87 9.94 7.74 7.29 7.37 7.68 7.55 8.14 8.47 8.09 7.70 5.12 5.99 3.33 3.97 4.54 3.97

March 31, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($172,568K + $150,067K + $—K) ÷ $39,910K
= 8.08

The quick ratio of Protagonist Therapeutics Inc has shown fluctuations over the periods analyzed. The quick ratio indicates the company's ability to meet its short-term obligations with its most liquid assets.

From Dec 31, 2019, to Mar 31, 2024, the quick ratio ranged from a low of 3.33 to a high of 16.06. The quick ratio generally remained above the ideal value of 1, indicating that Protagonist Therapeutics Inc has a strong ability to cover its short-term liabilities with its current liquid assets.

The quick ratio experienced a significant increase from Sep 30, 2020, to Dec 31, 2023, indicating strengthening liquidity position during this period. However, there were fluctuations in the quick ratio over other periods, suggesting variations in the company's ability to quickly cover its short-term obligations.

Overall, the trend of the quick ratio for Protagonist Therapeutics Inc reflects a generally healthy liquidity position, with some fluctuations indicating changing levels of short-term financial strength during the periods analyzed.


Peer comparison

Mar 31, 2024